Brief: Conmed Q2 Adjusted EPS USD 0.98 Vs. IBES Estimate USD 0.91
31/07/2024 21:05
Jul 31 (Reuters) - Conmed Q2 income from operations USD 47.107 million vs. IBES estimate USD 46.5 million. * Q2 sales USD 332.097 million vs. IBES estimate USD 332.3 million * Q2 EPS USD 0.96 * Q2 net income USD 29.976 million * Q2 pretax profit USD 37.514 million vs. IBES estimate USD 36.8 million * outlook FY adjusted EPS USD 3.95-4.02
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED